Rhode Island S2455 mandates insurance coverage for scalp cooling treatments for cancer patients undergoing chemotherapy.
Rhode Island S2455 amends the General Laws to require insurance coverage for scalp cooling treatments for cancer patients undergoing chemotherapy. Scalp cooling systems are defined as medical devices approved by the U.S. Food and Drug Administration designed to cool the scalp to prevent or reduce hair loss. The mandate applies to individual or group hospital or medical expense insurance policies and medical services plan contracts delivered, issued for delivery, or renewed in the state on or after January 1, 2027.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.